Could a shot of stem cell byproducts ease knee arthritis?
NCT ID NCT07157891
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This early-stage study tests whether an injection made from stem cell secretions and growth factors can safely reduce knee pain and improve joint function in people with mild to moderate knee osteoarthritis. About 25 adults aged 30-55 with early arthritis will receive the treatment and be monitored for side effects and symptom changes. The goal is to see if this cell-free approach can help control the disease without needing surgery or long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS (OA) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.